On December 30, astronomer Jonathan McDowell posted on X.com: “The abandoned Chandrayaan-3 propulsion module, left in a 125000 x 305000 km orbit in 2024, had a bit of a tussle with the Moon in ...

More than three-quarters of the global population is falling short on omega-3 intake, a nutrient gap that may increase the risk of heart disease, cognitive decline, inflammation and vision problems.

Share on Pinterest According to research, most people may not be getting enough omega-3 fatty acids in their diet. Image Credit: Tanja Ivanova/Getty Images A new research review reports that most ...

Most people worldwide aren’t getting enough omega-3, leaving a major gap between scientific recommendations and daily diets. Researchers emphasize the critical role of EPA and DHA across all life ...

ORLANDO, Fla., Dec. 9, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma, today announced new data from the investigational Phase 3 MajesTEC-3 study that ...

First, the phase 3 trial of Moderna’s norovirus vaccine had to endure a clinical hold. Now, the study has to head back for a second season in the Northern Hemisphere after failing to find enough cases ...

The RELIEVE trial assesses remibrutinib's efficacy and safety in generalized myasthenia gravis, involving 180 participants in a 6-month double-blind study. Remibrutinib has shown a positive safety ...

Astronomers are hustling to use interplanetary spacecraft to study the interstellar comet dubbed 3I/ATLAS while the sun is hiding it from Earth When Comet 3I/ATLAS roared into the solar system this ...

A new study examines the potential impact of healthy dietary fats on brain longevity. Findings imply that getting enough omega-3 fatty acids could protect women against Alzheimer’s disease. Below, ...

Please provide your email address to receive an email when new articles are posted on . Gildeuretinol helped patients maintain visual acuity for up to 7 years. The oral therapy was well tolerated.

Biogen has launched a late-stage study of its investigational drug felzartamab in the rare immune-mediated kidney disease primary membranous nephropathy, or PMN. Biogen on Monday said the phase 3 ...

The American Academy of Sleep Medicine has indicated that an estimated 26 percent of adults between the ages of 30 and 70 years have sleep apnea. (Photo: Getty) You could say that it’s difficult to ...